Good Patents - Bad Patents: Does protecting the pharmaceutical industry also benefit the most vulnerable?
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Good Patents - Bad Patents: Does protecting the pharmaceutical industry also benefit the most vulnerable?
-
Narrated by:
-
By:
About this listen
In our last episode before the German-Amrican Conference, our guests Prof. Dr. Timo Minssen and Sabrina Wimmer discuss the controverse topic on patent waivers and interlectual property rights in the pharmaceutical industry. Tune in for an interesting talk about the price of medicine, covid-vaccines and much more!
This podcast is supported by Wunderbartogether, an initiative founded by the federal foreign office to celebrate the German American friendship (https://www.wunderbar2gether.org/).
Intro/Outro & Post-Production: Emanuel Pavel (https://www.emanuelpavel.de/)
What listeners say about Good Patents - Bad Patents: Does protecting the pharmaceutical industry also benefit the most vulnerable?
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.